Endocrine Cancer

Lights Camera Action

William McCallum is living with stage 4 neuroendocrine cancer. This diagnosis is not easy to live with. Most days McCallum feels well enough that he doesn't think much about having cancer. After deciding to put his faith in his doctors, he aims not to worry. Acting in films for Rebel Pictures -- with his son, Michael -- has been both a welcome distraction and a creative outlet.

Read more about Lights Camera Action

Maria Papaleontiou MD

Read more about Maria Papaleontiou MD

Women’s sexual recovery after cancer

Sexual recovery during and after a women’s cancer diagnosis and treatment is as important as ensuring adequate nutrition, sleep and a healthy frame of mind. We spoke with Sallie Foley, LMSW, AASECT, co-author of "Sex Matters for Women," about sexual recovery after cancer for women who experience early menopause or menopause-like symptoms following cancer treatment.

Read more about Women’s sexual recovery after cancer

Imaging after thyroid cancer treatment does not necessarily mean better outcomes, study finds

More imaging after thyroid cancer treatment identifies recurrence, but it does not always improve survival, a new study suggests.

Read more about Imaging after thyroid cancer treatment does not necessarily mean better outcomes, study finds

Jonathan Brad Mchugh MD

Read more about Jonathan Brad Mchugh MD

Xin Jing BM

Read more about Xin Jing BM

Thomas James Giordano MD, PhD

Read more about Thomas James Giordano MD, PhD

U-M startup company secures license, funding to test potential drugs aimed at endocrine disorders

Millendo Therapeutics, a University of Michigan startup company, announced today that it has entered into an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to test a new compound, MLE4901, for the treatment of polycystic ovary syndrome.